Pancreatic Cancer Research

ResearcherVilnius UniversityActive in the last 2 years

Benediktas Kurlinkus

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9885-9347; OpenAlex author ID A5086870466. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 9

  1. Upfront surgery vs. neoadjuvant therapy in pancreatic cancer with venous involvement: a multicenter retrospective analysis. Co-author DOI 10.1007/s00423-026-04291-0↗
  2. Margin clearance greater than 1 mm in nodal-positive pancreatic adenocarcinoma patients: multicentre retrospective analysis. Co-author DOI 10.1093/bjsopen/zrae076↗
  3. The Prospect of Improving Pancreatic Cancer Diagnostic Capabilities by Implementing Blood Biomarkers: A Study of Evaluating Properties of a Single IL-8 and in … First author DOI 10.3390/biomedicines12102344↗
  4. Venous resection for pancreatic cancer, a safe and feasible option? A systematic review and meta-analysis. Co-author DOI 10.1016/j.pan.2022.05.001↗
  5. Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26. Co-author DOI 10.21873/anticanres.14897↗
  6. CEACAM6's Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6's Diagnostic and Prognostic Capabilities with Those… Co-author DOI 10.3390/life11060542↗
  7. In the Era of the Leeds Protocol: A Systematic Review and A Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma… Co-author DOI 10.1177/1457496920911807↗
  8. Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.12914↗
  9. Metabolomics in pancreatic cancer biomarkers research. Co-author DOI 10.1007/s12032-016-0853-6↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Audrius Šileikis · 5 shared papers, 2016–2024 · strength 0.78
  2. Asif Halimi · 4 shared papers, 2020–2026 · strength 0.72
  3. Eline S. Zwart · 4 shared papers, 2020–2026 · strength 0.72
  4. Johanna Laukkarinen · 4 shared papers, 2020–2026 · strength 0.72
  5. Reea Ahola · 4 shared papers, 2020–2026 · strength 0.72
  6. Guralp Onur Ceyhan · 4 shared papers, 2020–2026 · strength 0.72
  7. Giulio Belfiori · 2 shared papers, 2024–2026 · strength 0.42
  8. Patrick Maisonneuve · 2 shared papers, 2024–2026 · strength 0.42
  9. Keith John Roberts · 2 shared papers, 2024–2026 · strength 0.42
  10. Mindaugas Valius · 3 shared papers, 2018–2021 · strength 0.40
  11. Tomas Bukys · 1 shared paper, 2024 · strength 0.31
  12. Dalius Vitkus · 1 shared paper, 2024 · strength 0.31
  13. Marija Ger · 2 shared papers, 2018–2021 · strength 0.24
  14. Giuseppe Malleo · 1 shared paper, 2026 · strength 0.22
  15. Marco Del Chiaro · 1 shared paper, 2026 · strength 0.22
  16. Francesco Giovinazzo · 1 shared paper, 2026 · strength 0.22
  17. Laura Maggino · 1 shared paper, 2026 · strength 0.22
  18. Ernesto Sparrelid · 1 shared paper, 2026 · strength 0.22
  19. Elena B. Rangelova · 1 shared paper, 2026 · strength 0.22
  20. Gabriella Lionetto · 1 shared paper, 2026 · strength 0.22
  21. Massimo Falconi · 1 shared paper, 2026 · strength 0.22
  22. Geert Kazemier M · 1 shared paper, 2026 · strength 0.22
  23. Stefano Crippa · 1 shared paper, 2026 · strength 0.22
  24. Roberto Salvia · 1 shared paper, 2026 · strength 0.22
  25. Rupaly Pandé · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.